Clinical Trials Browser

Phase 1 × Neoplasms × ofatumumab × Clear all

NCT01691807 2018-02-28

Drug-drug Interaction Study of Ofatumumab With Bendamustine in Subjects With Indolent B-cell Non-Hodgkin's Lymphoma

Phase 1 Completed

Lymphoma, Non-Hodgkin, Neoplasms